Health

The 79th World Health Assembly is making crucial strides towards fortifying global health security, particularly focusing on the contentious Pathogen Access and Benefit Sharing (PABS) Annex of the WHO Pandemic Agreement. Amid reports from the Director-General and discussions on public health emergencies, the Assembly underscored the urgency of translating lessons from crises like COVID-19 into sustained investments and more equitable systems. The ongoing negotiations for the PABS Annex, deemed vital for the broader Pandemic Agreement's activation, highlight the complex balance between national interests and collective global health responsibilities, setting the stage for decisive discussions in the coming months.

The 79th World Health Assembly has concluded a pivotal session, endorsing major resolutions to reshape global health priorities. Delegates approved plans for a post-2030 tuberculosis strategy, recognized steatotic liver disease as a growing NCD burden, committed to closing equity gaps for haemophilia and other bleeding disorders, and addressed health mis- and disinformation as a critical public health threat. These decisions underscore a comprehensive and evolving strategy to confront both enduring and emerging health challenges worldwide.

The 79th World Health Assembly (WHA) concluded a pivotal day, highlighting the global health community's dual focus on immediate humanitarian crises and long-term systemic reforms. Against a backdrop of ongoing challenges, delegates celebrated significant contributions to public health while reaffirming commitments to regions in distress and charting a new course for managing pervasive noncommunicable diseases and mental health conditions.

The World Health Organization (WHO) has issued a dire warning, revealing that at least 40 million children globally are using tobacco products, a figure exacerbated by the rapid rise in e-cigarette and nicotine pouch consumption among young people. Ahead of World No Tobacco Day, the WHO is urgently calling on governments worldwide to implement robust measures to protect adolescents from what it describes as a new generation being deliberately targeted and hooked by the tobacco and nicotine industry. The organization highlights aggressive marketing strategies, including appealing flavors, social media influencers, and lifestyle branding, which circumvent existing regulations and threaten public health.

The World Health Organization (WHO) has convened expert groups, including its R&D Blueprint technical advisory groups and the Strategic Advisory Group of Experts on Immunization (SAGE), to assess potential countermeasures for the ongoing Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of Congo and Uganda. In a crucial decision, these advisory bodies have recommended that all identified candidate vaccines and therapeutics for BVD must be evaluated exclusively within rigorously designed clinical trials. This directive underscores the absence of any currently licensed treatments or vaccines specifically targeting BVD, highlighting the urgent need for robust scientific data to ensure the safety and efficacy of these promising products.

In an unprecedented and deeply personal message, WHO Director-General Tedros Adhanom Ghebreyesus has called for an immediate ceasefire in the Democratic Republic of Congo's Ituri province, grappling with a new and particularly dangerous Ebola outbreak. Unlike previous strains, this resurgence is driven by Ebola Bundibugyo, for which there are currently no approved vaccines or treatments. With over 90% of cases reported in Ituri, a region already devastated by armed conflict, displacement, and multiple health crises, the WHO chief's appeal underscores the critical need for unhindered humanitarian access and community trust to avert a catastrophe.

The World Health Organization (WHO) has officially designated the ongoing Ebola Bundibugyo virus disease (BVD) epidemic in the Democratic Republic of Congo (DRC) and Uganda as a Public Health Emergency of International Concern (PHEIC). This declaration, made in May 2026, underscores the severe risk posed by the BDBV strain, for which no approved vaccines or therapeutics currently exist. The WHO Director-General, supported by the IHR Emergency Committee, issued temporary recommendations to affected and preparing nations, emphasizing immediate public health interventions amidst challenging operational environments.

At the 79th World Health Assembly, Member States approved critical initiatives to modernize global health architecture, manage the geopolitical and digital shifts of the 2020s, and address urgent public health issues, including a landmark stroke resolution and guidelines on AI-integrated healthcare.

The 79th World Health Assembly in Geneva concluded with significant advancements across the global health landscape. Member States adopted numerous resolutions and decisions, initiating reforms to the global health architecture and updating crucial policies. Key outcomes include the first major revision in 16 years to the WHO Code on ethical international recruitment of health personnel, a new strategy linking economic systems to health for all, a comprehensive approach to radiation protection, and a renewed Global Action Plan to combat the escalating threat of antimicrobial resistance (AMR), targeting a 10% reduction in associated deaths by 2030.